Showing 590 results
Archival description![[H] ERL article metric for news outlets](/uploads/r/null/a/f/e/afebaaa7b739991eff6dda0851921347668fa71448ffe7a5396794bf4c05c4ba/634bb99a-0e22-4369-a2b9-debaa9359343-_H__iop-altmetric-details-news-2020-04-08-14_49_53_142.jpg)
[H] ERL article metric for news outlets
![[H] ECONIC WINS SHELL UK CHAIRMAN SPECIAL AWARD AT SHELL SPRINGBOARD 2015!](/uploads/r/null/0/5/4/05412c6a9b6f59f5c229c59db1cd6ad7925fa3f625cdda4f567f311c8c17c5f6/adfe7369-a1b9-483d-8f57-9402202f0e1a-_H__econic-technologies-news-econic-wins-shell-uk-chairman-special-award-shell-springboard-2015-2020-10-13-14_54_00_142.jpg)
[H] ECONIC WINS SHELL UK CHAIRMAN SPECIAL AWARD AT SHELL SPRINGBOARD 2015!
![[H] ECONIC NAMED 2019 GLOBAL CLEANTECH 100 COMPANY](/uploads/r/null/e/d/b/edbcf5cd7024247849e7308272a6996f7fa83752f9efb0a293d97337ccf818cc/2e5d2fbc-1285-4c5b-a530-2c2d176f277d-_H__econic-technologies-news-econic-2019-global-cleantech-100-company-2020-10-13-14_54_10_142.jpg)
[H] ECONIC NAMED 2019 GLOBAL CLEANTECH 100 COMPANY
![[H] Combined evidence of impact related to Tier 4 restrictions within England](/uploads/r/null/3/3/e/33e262b18b3b1e43995e55414aa9ddc69f764ae2d3bf8b8f209e3ecb87a5d333/eee6ec0f-b6f5-4fd1-9f4a-20ef5d52d22b-_H__Combined_Tier_4_Evidence_England_142.jpg)
[H] Combined evidence of impact related to Tier 4 restrictions within England
![[H] Cairn Fluorescence Lifetime Imaging Module - Technical Description](/uploads/r/null/f/1/3/f138992355f37f0f469f95137604723ddf63d0bcf854de220b9cd554ddbeb754/d1bf3e07-5025-4cd2-9d0a-0c7bf2276c4a-_H__screencapture-cairn-research-co-uk-product-fluorescence-lifetime-imaging-module-2021-01-18-10_31_29_142.jpg)
[H] Cairn Fluorescence Lifetime Imaging Module - Technical Description
![[H] BLADE test flight](/uploads/r/null/a/4/7/a47152afd8af12882e4589ea990be2da5cd6287a55d15cdf900c0dd672164be9/b6c87fe2-c114-4488-82a5-03fd9050236c-_H__BLADE_test_flight_142.jpg)
[H] BLADE test flight
![[H] Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Million.pdf](/uploads/r/null/b/6/b/b6bcfb31ec4ca5fef433ab715a8256c5e27bb64eea4d3420f9c169f9917b8da1/bf9498a2-08ec-4b2a-9eda-0e2643c1b7e3-_H__Biogen_Completes_Acquisition_of_Nightstar_Therapeutics_for_Approximately__800_Million_142.jpg)
[H] Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Million.pdf
![[H] BCG report on Quantum Computing](/uploads/r/null/a/4/e/a4ee047c932efdb0bdbef77bc43316ef96f2fe10d4d2522068599e42b887a77d/8b6bda2d-f45d-4de6-b0a4-400246b18557-_H__bcg-publications-2018-coming-quantum-leap-computing-2020-04-08-14_29_46_142.jpg)
[H] BCG report on Quantum Computing
![[H] Austrian Special Report 2018 Health, Demography and Climate Change.](/uploads/r/null/4/6/c/46c7905511e73de299cdd5e4520aca2dcafcf6828a7456988687b8a0185b3839/9731338b-d922-4035-a7ab-fb8735db59e4-_H__APCC_ASR18_142.jpg)
[H] Austrian Special Report 2018 Health, Demography and Climate Change.
![[H] Adenoma_surveillance_second_edition withdrawn.pdf](/uploads/r/null/1/f/b/1fbf486beddc2c91806ee3f77e9fd136411bc34129488c81ae37ff0364a6c0c2/fe81758e-9633-4f5a-a1e2-f5376035fcac-_H__Adenoma_surveillance_second_edition_withdrawn_142.jpg)
[H] Adenoma_surveillance_second_edition withdrawn.pdf
![[H] Acoustics: Sound Economy (The Value of Acoustics) Report](/uploads/r/null/9/e/c/9ecd89125757a66a6c59ff516389bc1b41e9d385feb058f441ad3a7e11d82316/194f3b4a-f187-45fc-971f-849040a359e4-_H__Acoustics-sound-economy-report-May-2019_142.jpg)
[H] Acoustics: Sound Economy (The Value of Acoustics) Report
![[G] Guidelines for the Treatment of Latent Tuberculosis Infection Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 Morbidity and Mortality Weekly Report February 14 2020.pdf](/uploads/r/null/4/6/e/46ed66d453821f0ddccadce5494a4e14439887fe2a0f1a6659e92729d89545c6/e42813dc-061f-4c04-89f6-a6dc91eafef5-_G__Guidelines_for_the_Treatment_of_Latent_Tuberculosis_Infection_Recommendations_from_the_National_Tuberculosis_Controllers_Association_and_CDC__2020_Morbidity_and_Mortality_Weekly_Report_February_14_2020_142.jpg)
[G] Guidelines for the Treatment of Latent Tuberculosis Infection Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 Morbidity and Mortality Weekly Report February 14 2020.pdf
![[Giv] Health Service Commissioning of TrikaftaKaftrio NHS Scotland.pdf](/uploads/r/null/0/9/0/09048357648e2b8fc29f11fffb97b91e09a24886e98fbddc0dca4b182f65cd18/a5b03f20-5da0-4b70-87bd-9fc74875f2a2-_Giv__Health_Service_Commissioning_of_TrikaftaKaftrio_NHS_Scotland_142.jpg)
[Giv] Health Service Commissioning of TrikaftaKaftrio NHS Scotland.pdf
![[Giii] Health Service Commissioning of TrikaftaKaftrio Northern Ireland.pdf](/uploads/r/null/c/f/b/cfb1b31923f41e01a108288ec61634772d5a1dc918bb35888dda3f0ae8e33eaa/d0bfc5e3-cfe6-4be6-951d-d2286ffc7dad-_Giii__Health_Service_Commissioning_of_TrikaftaKaftrio_Northern_Ireland_142.jpg)
[Giii] Health Service Commissioning of TrikaftaKaftrio Northern Ireland.pdf
![[Gii] WHO Guidance for Country Level Strategic Planning From malaria control to malaria elimination: a manual for elimination scenario planning.](/uploads/r/null/4/b/0/4b00c4f84c1600f1ee9dc21c4cd6e030708d07484757c7a5c5f6da5f5317ec91/4facab95-c66b-4902-8d54-69ec0849cd05-_Gii__9789241507028_eng_142.jpg)
[Gii] WHO Guidance for Country Level Strategic Planning From malaria control to malaria elimination: a manual for elimination scenario planning.
![[Gii] Health Service Commissioning of TrikaftaKaftrio NHS Wales.pdf](/uploads/r/null/7/4/9/7499a3f3f1f1dcef0858488e8a0fc40f7d3c1974bdd7896bd1e4f552741e1707/10964f43-4c31-4fea-9e46-a0a4fa9b0f1a-_Gii__Health_Service_Commissioning_of_TrikaftaKaftrio_NHS_Wales_142.jpg)
[Gii] Health Service Commissioning of TrikaftaKaftrio NHS Wales.pdf
![[Gii] Hansard 2016 Volume 605 debated on Thursday 11 February 2016 Secretary of State for Health.pdf](/uploads/r/null/3/5/b/35bca4ff4a5dfe31c826cdb0a6819b517d71c3107bd38002e00f825cf69c0eda/f55da13b-d7fb-40f7-a593-12c23c2ce194-_Gii__Hansard_2016_Volume_605_debated_on_Thursday_11_February_2016__Secretary_of_State_for_Health_142.jpg)
[Gii] Hansard 2016 Volume 605 debated on Thursday 11 February 2016 Secretary of State for Health.pdf
![[Gi] WHO Guidance for Country Level Strategic Planning: Web page](/uploads/r/null/b/6/2/b62d1d9326e3027bcc099ff47453a3c4f4184dd0e68ab8617abdce3792b9d4b2/474a63e2-68b0-4de5-9dca-346d2474b116-_Gi__who-int-malaria-publications-atoz-9789241507028-en-2021-02-01-09_53_17_142.jpg)
[Gi] WHO Guidance for Country Level Strategic Planning: Web page
![[Gi] Health Service Commissioning of TrikaftaKaftrio NHS England.pdf](/uploads/r/null/5/6/7/5679d95879085b5cf3c340b33165aac0aa4a93dc172e884f5cb5f21775c07feb/e1b1cfef-9479-4860-aedf-4cc23f19e733-_Gi__Health_Service_Commissioning_of_TrikaftaKaftrio_NHS_England_142.jpg)
[Gi] Health Service Commissioning of TrikaftaKaftrio NHS England.pdf
![[Gi] Hansard 2016 Volume 605 debated on Thursday 11 February 2016 Secretary of State for Health.pdf](/uploads/r/null/9/6/4/964c3394029cb22f88d75f9d2130ef977bce90b14e7081574020fcdc9983f5ea/7d759e45-e914-4852-ae29-4a99487a17a0-_Gi__Hansard_2016_Volume_605_debated_on_Thursday_11_February_2016__Secretary_of_State_for_Health_142.jpg)
[Gi] Hansard 2016 Volume 605 debated on Thursday 11 February 2016 Secretary of State for Health.pdf